SCHEMBL4964339

SCHEMBL4964339

O=C(O)N1CCCCC1Cc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.61
DAGLA Q9Y4D2 12/20 0.57
ABHD6 Q9BV23 8/20 0.57
MEN1 O00255 1/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
KMT2A Q03164 1/20 0.56
DPP4 P27487 1/20 0.55
SCD5 Q86SK9 1/20 0.53
DAGLB Q8NCG7 2/20 0.53
GABRA1 P14867 1/20 0.52
GABRG2 P18507 1/20 0.52
GABRB3 P28472 1/20 0.52
GABRA3 P34903 1/20 0.52
GABRA2 P47869 1/20 0.52
GABRB2 P47870 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4629395 1.00 HSD11B1 (0.61) HSD11B1DAGLAABHD6MEN1NPC1
Hydrochloric Acid SCHEMBL29238125 0.98 HSD11B1 (0.60) HSD11B1DAGLAABHD6MEN1NPC1
SCHEMBL23459127 0.95 SCD5 (0.57) HSD11B1DAGLAABHD6MEN1NPC1
SCHEMBL908981 0.95 SCD5 (0.57) HSD11B1DAGLAABHD6MEN1NPC1
SCHEMBL18862950 0.88 HSD11B1 (0.48) HSD11B1DAGLAABHD6SCD5GABRA1
SCHEMBL18862951 0.88 HSD11B1 (0.48) HSD11B1DAGLAABHD6SCD5GABRA1
SCHEMBL21138521 0.88 HSD11B1 (0.62) HSD11B1DAGLAABHD6MEN1NPC1
SCHEMBL27651068 0.88 HSD11B1 (0.58) HSD11B1DAGLAABHD6MEN1NPC1
SCHEMBL6429540 0.88 HSD11B1 (0.58) HSD11B1DAGLAABHD6MEN1NPC1
SCHEMBL11481440 0.86 HSD11B1 (0.57) HSD11B1DAGLAABHD6MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108699032-B Polycyclic TLR7/8 antagonists and their use in the treatment of immune disorders 默克专利有限公司 2022-07-22 CN disclosed
CN-113603675-A Polycyclic TLR7/8 antagonists and their use in the treatment of immune disorders 默克专利有限公司 2021-11-05 CN disclosed
EP-3440078-A1 HETEROCYCLIC GPR119 AGONIST COMPOUNDS MANKIND PHARMA LTD (IN) 2019-02-13 EP disclosed
WO-2017175066-A1 HETEROCYCLIC GPR119 AGONIST COMPOUNDS MANKIND PHARMA LTD. (IN) 2017-10-12 WO disclosed
EP-1879873-A1 NEUROTHERAPEUTIC AZOLE COMPOUNDS SK Holdings Co., Ltd. (KR) 2008-01-23 EP disclosed
WO-2006112685-A1 NEUROTHERAPEUTIC AZOLE COMPOUNDS SK HOLDINGS CO., LTD. (KR) 2006-10-26 WO disclosed